We are live on ! Find out more
KCM

Kennedy Capital Management Portfolio holdings

AUM $4.72B
1-Year Est. Return 36.69%
This Fund
S&P 500
This Quarter Est. Return
+11.05%
1 Year Est. Return
+36.69%
3 Year Est. Return
+98.85%
5 Year Est. Return
+128.89%
10 Year Est. Return
+548.51%
AUM
$4.53B
AUM Growth
-$150M
Cap. Flow
-$510M
Cap. Flow %
-11.27%
Top 10 Hldgs %
8.72%
Holding
765
New
71
Increased
198
Reduced
404
Closed
78

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$11.4M
2
EW icon
Edwards Lifesciences
EW
+$11.1M
3
RNST icon
Renasant Corp
RNST
+$10.9M
4
AAPL icon
Apple
AAPL
+$9.67M
5
NCNO icon
nCino
NCNO
+$9.65M

Top Sells

Rank Stock Value
1
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$20.2M
2
TBBK icon
The Bancorp
TBBK
+$15.8M
3
AIZ icon
Assurant
AIZ
+$12.5M
4
NDSN icon
Nordson
NDSN
+$12.5M
5
VAC icon
Marriott Vacations Worldwide
VAC
+$12.4M

Sector Composition

Rank Sector Weight
1 Financials 20.06%
2 Industrials 18.84%
3 Healthcare 17.71%
4 Technology 13.16%
5 Consumer Discretionary 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VABK icon
626
Virginia National Bankshares
VABK
$254M
$611K 0.01%
+14,678
New +$550K
FNWB icon
627
First Northwest Bancorp
FNWB
$105M
$564K 0.01%
+52,668
New +$546K
ASYS icon
628
Amtech Systems
ASYS
$264M
$557K 0.01%
96,111
-91,080
-49% -$555K
SKYW icon
629
Skywest
SKYW
$4.18B
$554K 0.01%
6,512
-2,012
-24% -$158K
MRVI icon
630
Maravai LifeSciences
MRVI
$904M
$549K 0.01%
66,125
-21,223
-24% -$183K
JANX icon
631
Janux Therapeutics
JANX
$1B
$535K 0.01%
11,785
+1,805
+18% +$78.5K
XGN icon
632
Exagen
XGN
$161M
$524K 0.01%
169,553
+93,040
+122% +$241K
ROIV icon
633
Roivant Sciences
ROIV
$25.8B
$497K 0.01%
43,107
+6,194
+17% +$70.5K
NUVL
634
DELISTED
Nuvalent
NUVL
$471K 0.01%
4,600
+659
+17% +$54.7K
SFBC
635
Sound Financial Bancorp
SFBC
$110M
$468K 0.01%
+8,740
New +$429K
PLAY icon
636
Dave & Buster's
PLAY
$343M
$465K 0.01%
+13,658
New +$466K
BNTX icon
637
BioNTech
BNTX
$23.3B
$458K 0.01%
+3,856
New +$354K
USAP
638
DELISTED
Universal Stainless & Alloy
USAP
$448K 0.01%
11,603
+1,520
+15% +$54.2K
VSTO
639
DELISTED
Vista Outdoor Inc.
VSTO
$439K 0.01%
11,200
+1,494
+15% +$57.9K
BHVN icon
640
Biohaven
BHVN
$2.19B
$424K 0.01%
8,484
-204,547
-96% -$7.96M
IRWD icon
641
Ironwood Pharmaceuticals
IRWD
$669M
$422K 0.01%
102,477
-1,339
-1% -$7.2K
PWP icon
642
Perella Weinberg Partners
PWP
$1.26B
$376K 0.01%
19,463
+2,581
+15% +$47.3K
BPMC
643
DELISTED
Blueprint Medicines
BPMC
$353K 0.01%
3,816
+547
+17% +$54.3K
NTRA icon
644
Natera
NTRA
$45.9B
$350K 0.01%
2,754
-1,287
-32% -$148K
HBIO icon
645
Harvard Bioscience
HBIO
$28.8M
$346K 0.01%
12,854
-19,161
-60% -$564K
ITCI
646
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$343K 0.01%
4,682
+1,108
+31% +$83.3K
ABSI icon
647
Absci
ABSI
$1.53B
$339K 0.01%
88,622
+12,641
+17% +$50.3K
TNL icon
648
Travel + Leisure Co
TNL
$4.5B
$336K 0.01%
7,300
– –
FTDR icon
649
Frontdoor
FTDR
$5.78B
$334K 0.01%
6,951
– –
BOOM icon
650
DMC Global
BOOM
$153M
$330K 0.01%
25,386
-312,750
-92% -$3.96M
24 25
26
27 28

Similar funds

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
VDI
Vaughan David Investments Peoria, Illinois $4.73B AUM 19.55% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return
JCM
Junto Capital Management New York $4.74B AUM 27.96% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return
RC
Resolution Capital Sydney, NSW, Australia $4.76B AUM 10.22% 1-Year Est. Return

Kennedy Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Kennedy Capital Management held 765 positions worth $4.53B, down 3.2% from $4.68B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

Kennedy Capital Management withdrew a net $510M in Q3 2024, closing 78 positions and reducing 404 holdings. Its most notable exit was Silk Road Medical, Inc. Common Stock, an estimated $20.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Kennedy Capital Management opened a new position in Edwards Lifesciences worth $10.1M.

  • Kennedy Capital Management's largest Q3 2024 buy was Edwards Lifesciences: 153,046 shares worth $10.1M.
  • Kennedy Capital Management added most to Microsoft in Q3 2024, an estimated $11.4M increase.
  • Kennedy Capital Management's biggest Q3 2024 reduction was The Bancorp, cutting an estimated $15.8M.
  • Kennedy Capital Management fully exited Silk Road Medical, Inc. Common Stock in Q3 2024, selling an estimated $20.2M.
  • Kennedy Capital Management's ten largest holdings make up 8.7% of its $4.53B portfolio in Q3 2024.
  • Kennedy Capital Management opened 71 new positions and closed 78 in Q3 2024.
  • Kennedy Capital Management's portfolio value fell 3.2% quarter-over-quarter to $4.53B.

Based on Kennedy Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.